Related references
Note: Only part of the references are listed.Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
Kathleen M. Mullane et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clostridium difficile Outbreak Strain BI Is Highly Endemic in Chicago Area Hospitals
Stephanie R. Black et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Clostridium difficile infection in Europe: a hospital-based survey
Martijn P. Bauer et al.
LANCET (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007
Adam K. Cheknis et al.
ANAEROBE (2009)
OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C-difficile Infection
Thomas J. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)
M. P. Bauer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile
Paul L. Hinkson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system
Jaime Belmares et al.
JOURNAL OF INFECTION (2007)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Emergence of Clostridium difficile-associated disease in North America and Europe
E. J. Kuijper et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile -: Associated diarrhea
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2006)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
M Warny et al.
LANCET (2005)
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
DM Musher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Factors associated with failure of metronidazole in Clostridium difficile-associated disease
A Fernandez et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Share Paper
